Fertilite İlaçları ve Kanser

Vassard D, Schmidt L, Glazer C, et al. Assisted reproductive technology treatment and risk of ovarian cancer—a nationwide population-based cohort study. Human Reproduction. 2019;34(11):2290-2296. doi: 10.1093/humrep/dez165.

Kristensen AK, Frandsen CLB, Nøhr B, et al. Risk of borderline ovarian tumors after fertility treatment-Results from a Danish cohort of infertile women. Gynecologic Oncology. 2024;185:108-115. doi: 10.1016/j.ygyno.2024.02.013.

Liu X, Yue J, Pervaiz R, et al. Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis. Frontiers in Endocrinology. 2022;13:986477. doi: 10.3389/fendo.2022.986477.

Cullinane C, Gillan H, Geraghty J, et al. Fertility treatment and breast-cancer incidence: meta-analysis. BJS open. 2022;6(1):zrab149. doi: 10.1093/bjsopen/zrab149.

Lindquist S, Kjær SK, Albieri V, et al. Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women. Human Reproduction. 2022;37(4):838-847. doi: 10.1093/humrep/deab285.

Yu L, Sun J, Wang Q, et al. Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis. Journal of Ovarian Research. 2023;16(1):22. doi: 10.1186/s13048-022-01084-z.

Medicine PCotASfR. Fertility drugs and cancer: a guideline. Fertility and Sterility. 2024;122(3):406-420. doi: 10.1016/j.fertnstert.2024.03.026.

Jiang YT, Gong TT, Zhang JY, et al. Infertility and ovarian cancer risk: evidence from nine prospective cohort studies. International Journal of Cancer. 2020;147(8):2121-2130. doi: 10.1002/ijc.33012.

Williams CL, Jones ME, Swerdlow AJ, et al. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ. 2018;362:k2644. doi: 10.1136/bmj.k2644.

Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane database of systematic reviews. 2019;6:CD008215. doi: 10.1002/14651858.CD008215.pub3.

Perri T, Lifshitz D, Sadetzki S, et al. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. Fertility and Sterility. 2015;103(5):1305-1312. doi: 10.1016/j.fertnstert.2015.02.011.

Lundberg FE, Johansson AL, Rodriguez-Wallberg K, et al. Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. European journal of epidemiology. 2019;34(11):1093-1101. doi: 10.1007/s10654-019-00540-3.

Barcroft JF, Galazis N, Jones BP, et al. Fertility treatment and cancers—the eternal conundrum: a systematic review and meta-analysis. Human Reproduction. 2021;36(4):1093-1107. doi: 10.1093/humrep/deaa293.

Brinton LA, Scoccia B, Moghissi KS, et al. Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer epidemiology, biomarkers & prevention. 2014;23(4):584-593. doi: 10.1158/1055-9965.EPI-13-0996.

van den Belt-Dusebout AW, Spaan M, Lambalk CB, et al. Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer. JAMA. 2016;316(3):300-312. doi: 10.1001/jama.2016.9389.

Beebeejaun Y, Athithan A, Copeland TP, et al. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Fertility and sterility. 2021;116(1):198-207. doi: 10.1016/j.fertnstert.2021.01.044.

Skalkidou A, Sergentanis TN, Gialamas SP, et al. Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility. Cochrane Database of Systematic Reviews. 2017;3:CD010931. doi: 10.1002/14651858.CD010931.pub2.

Yu Q, Lv X, Liu K, et al. Fertility drugs associated with thyroid cancer risk: a systematic review and meta‐analysis. BioMed Research International. 2018;2018(1):7191704. doi: 10.1155/2018/7191704.

Murugappan G, Li S, Lathi RB, et al. Risk of cancer in infertile women: analysis of US claims data. Human Reproduction. 2019;34(5):894-902. doi: 10.1093/humrep/dez018.

Hannibal CG, Jensen A, Sharif H, et al. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes & Control. 2008;19:759-765. doi: 10.1007/s10552-008-9138-5.

Brinton LA, Moghissi KS, Scoccia B, et al. Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertility and sterility. 2015;104(4):980-988. doi: 10.1016/j.fertnstert.2015.06.045.

Pinborg A, Wennerholm U-B, Bergh C. Long-term outcomes for children conceived by assisted reproductive technology. Fertility and Sterility. 2023;120(3):449-456. doi: 10.1016/j.fertnstert.2023.04.022.

Ayhan A, Salman MC, Çelik H, et al. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers. Acta Obstetricia et Gynecologica Scandinavica. 2004; 83:1104-1111. doi: 10.1080/j.0001-6349.2004.00669.x.

Weng S-S, Huang Y-T, Huang Y-T, et al. Assisted reproductive technology and risk of childhood cancers. JAMA network open. 2022;5(8):e2230157-e. doi: 10.1001/jamanetworkopen.2022.30157.

Zhang Y, Gao R, Chen H, et al. The association between fertility treatments and the incidence of paediatric cancer: a systematic review and meta-analysis. European Journal of Cancer. 2020;138:133-148. doi: 10.1016/j.ejca.2020.08.001.

Vassard D, Schmidt L, Glazer C, et al. Assisted reproductive technology treatment and risk of ovarian cancer—a nationwide population-based cohort study. Human Reproduction. 2019;34(11):2290-2296. doi: 10.1093/humrep/dez165.

Kristensen AK, Frandsen CLB, Nøhr B, et al. Risk of borderline ovarian tumors after fertility treatment-Results from a Danish cohort of infertile women. Gynecologic Oncology. 2024;185:108-115. doi: 10.1016/j.ygyno.2024.02.013.

Liu X, Yue J, Pervaiz R, et al. Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis. Frontiers in Endocrinology. 2022;13:986477. doi: 10.3389/fendo.2022.986477.

Cullinane C, Gillan H, Geraghty J, et al. Fertility treatment and breast-cancer incidence: meta-analysis. BJS open. 2022;6(1):zrab149. doi: 10.1093/bjsopen/zrab149.

Lindquist S, Kjær SK, Albieri V, et al. Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women. Human Reproduction. 2022;37(4):838-847. doi: 10.1093/humrep/deab285.

Yu L, Sun J, Wang Q, et al. Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis. Journal of Ovarian Research. 2023;16(1):22. doi: 10.1186/s13048-022-01084-z.

Medicine PCotASfR. Fertility drugs and cancer: a guideline. Fertility and Sterility. 2024;122(3):406-420. doi: 10.1016/j.fertnstert.2024.03.026.

Jiang YT, Gong TT, Zhang JY, et al. Infertility and ovarian cancer risk: evidence from nine prospective cohort studies. International Journal of Cancer. 2020;147(8):2121-2130. doi: 10.1002/ijc.33012.

Williams CL, Jones ME, Swerdlow AJ, et al. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ. 2018;362:k2644. doi: 10.1136/bmj.k2644.

Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane database of systematic reviews. 2019;6:CD008215. doi: 10.1002/14651858.CD008215.pub3.

Perri T, Lifshitz D, Sadetzki S, et al. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. Fertility and Sterility. 2015;103(5):1305-1312. doi: 10.1016/j.fertnstert.2015.02.011.

Lundberg FE, Johansson AL, Rodriguez-Wallberg K, et al. Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. European journal of epidemiology. 2019;34(11):1093-1101. doi: 10.1007/s10654-019-00540-3.

Barcroft JF, Galazis N, Jones BP, et al. Fertility treatment and cancers—the eternal conundrum: a systematic review and meta-analysis. Human Reproduction. 2021;36(4):1093-1107. doi: 10.1093/humrep/deaa293.

Brinton LA, Scoccia B, Moghissi KS, et al. Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer epidemiology, biomarkers & prevention. 2014;23(4):584-593. doi: 10.1158/1055-9965.EPI-13-0996.

van den Belt-Dusebout AW, Spaan M, Lambalk CB, et al. Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer. JAMA. 2016;316(3):300-312. doi: 10.1001/jama.2016.9389.

Beebeejaun Y, Athithan A, Copeland TP, et al. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Fertility and sterility. 2021;116(1):198-207. doi: 10.1016/j.fertnstert.2021.01.044.

Skalkidou A, Sergentanis TN, Gialamas SP, et al. Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility. Cochrane Database of Systematic Reviews. 2017;3:CD010931. doi: 10.1002/14651858.CD010931.pub2.

Yu Q, Lv X, Liu K, et al. Fertility drugs associated with thyroid cancer risk: a systematic review and meta‐analysis. BioMed Research International. 2018;2018(1):7191704. doi: 10.1155/2018/7191704.

Murugappan G, Li S, Lathi RB, et al. Risk of cancer in infertile women: analysis of US claims data. Human Reproduction. 2019;34(5):894-902. doi: 10.1093/humrep/dez018.

Hannibal CG, Jensen A, Sharif H, et al. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes & Control. 2008;19:759-765. doi: 10.1007/s10552-008-9138-5.

Brinton LA, Moghissi KS, Scoccia B, et al. Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertility and sterility. 2015;104(4):980-988. doi: 10.1016/j.fertnstert.2015.06.045.

Pinborg A, Wennerholm U-B, Bergh C. Long-term outcomes for children conceived by assisted reproductive technology. Fertility and Sterility. 2023;120(3):449-456. doi: 10.1016/j.fertnstert.2023.04.022.

Ayhan A, Salman MC, Çelik H, et al. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers. Acta Obstetricia et Gynecologica Scandinavica. 2004; 83:1104-1111. doi: 10.1080/j.0001-6349.2004.00669.x.

Weng S-S, Huang Y-T, Huang Y-T, et al. Assisted reproductive technology and risk of childhood cancers. JAMA network open. 2022;5(8):e2230157-e. doi: 10.1001/jamanetworkopen.2022.30157.

Zhang Y, Gao R, Chen H, et al. The association between fertility treatments and the incidence of paediatric cancer: a systematic review and meta-analysis. European Journal of Cancer. 2020;138:133-148. doi: 10.1016/j.ejca.2020.08.001.